Author

Fabienne Venet

Lyon 1 UniversitéORCID 0000-0003-0462-4235Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:statistical model· 1

Frequent Co-Authors

Yvan JamillouxiD· 2 shared A. DuquesneiD· 1 shared Abdelrahim ZouediD· 1 shared Alexandre BélotiD· 1 shared Alexandre Thibault Jacques MariaiD· 1 shared Amaury ReyiD· 1 shared Anne PagnieriD· 1 shared Anne‐Claire LukaszewicziD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Yvan JamillouxORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintMar 9, 2026

Functional alterations of immune gene expression in ICU and non-ICU patients with Legionnaires' disease, a prospective observational study

Camille Allam, William Mouton, Chloé Albert Vega…·Sophie Jarraud

This study compares immune gene expression in ICU and non-ICU Legionnaires' disease patients after LPS stimulation, finding more pronounced functional impairments in ICU patients.

DOI 10.64898/2026.03.06.709905

humanbulk RNA-seq

𝕏 PostBluesky

ImmunologyThe Journal of Experimental MedicinePeer-reviewedFeb 28, 2024

Functional diversity of NLRP3 gain-of-function mutants associated with CAPS autoinflammation.

Camille Cosson, Romane Riou, Danish Patoli…·Bénédicte F. Py

This study functionally characterizes 34 NLRP3 variants associated with CAPS, identifying functional diversity and inhibitor sensitivity, with implications for diagnosis and drug development.

56 citationstop 2%

humanexperimental assay

𝕏 PostBluesky